GeoVax Labs Inc. [NASDAQ: GOVX] jumped around 0.11 points on Tuesday, while shares priced at $1.70 at the close of the session, up 6.92%. The company report on July 26, 2022 that GeoVax to Report Second Quarter 2022 Financial Results on Wednesday, August 3, 2022 and Provide Corporate Update.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
Conference Call to be Held Wednesday, August 3, at 4:30 p.m. Eastern Time.
via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against infectious diseases and cancer, announces today that it will report second quarter 2022 financial results on Wednesday, August 3, 2022 after the market closes.
GeoVax Labs Inc. stock is now -53.04% down from its year-to-date (YTD) trading value. GOVX Stock saw the intraday high of $2.48 and lowest of $1.53 per share. The company’s 52-week high price is 7.50, which means current price is +209.37% above from all time high which was touched on 01/03/22.
Compared to the average trading volume of 13.66M shares, GOVX reached a trading volume of 201513131 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about GeoVax Labs Inc. [GOVX]?
Maxim Group have made an estimate for GeoVax Labs Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on November 19, 2020.
The Average True Range (ATR) for GeoVax Labs Inc. is set at 0.23, with the Price to Sales ratio for GOVX stock in the period of the last 12 months amounting to 58.23. The Price to Book ratio for the last quarter was 1.06, with the Price to Cash per share for the same quarter was set at 1.19.
How has GOVX stock performed recently?
GeoVax Labs Inc. [GOVX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 152.64. With this latest performance, GOVX shares gained by 34.92% in over the last four-week period, additionally sinking by -25.11% over the last 6 months – not to mention a drop of -59.13% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GOVX stock in for the last two-week period is set at 72.48, with the RSI for the last a single of trading hit 83.06, and the three-weeks RSI is set at 64.97 for GeoVax Labs Inc. [GOVX]. The present Moving Average for the last 50 days of trading for this stock 1.2167, while it was recorded at 1.0630 for the last single week of trading, and 2.2599 for the last 200 days.
GeoVax Labs Inc. [GOVX]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and GeoVax Labs Inc. [GOVX] shares currently have an operating margin of -4862.72. GeoVax Labs Inc.’s Net Margin is presently recorded at -4817.19.
Return on Equity for this stock declined to -266.61, with Return on Assets sitting at -167.37.
GeoVax Labs Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.80 and a Current Ratio set at 4.80.
Insider trade positions for GeoVax Labs Inc. [GOVX]
There are presently around $2 million, or 14.90% of GOVX stock, in the hands of institutional investors. The top three institutional holders of GOVX stocks are: ARMISTICE CAPITAL, LLC with ownership of 435,150, which is approximately New of the company’s market cap and around 0.40% of the total institutional ownership; VANGUARD GROUP INC, holding 258,766 shares of the stock with an approximate value of $0.41 million in GOVX stocks shares; and GEODE CAPITAL MANAGEMENT, LLC, currently with $84000.0 in GOVX stock with ownership of nearly 0% of the company’s market capitalization.
Positions in GeoVax Labs Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 8 institutional holders increased their position in GeoVax Labs Inc. [NASDAQ:GOVX] by around 538,397 shares. Additionally, 7 investors decreased positions by around 54,730 shares, while 5 investors held positions by with 353,129 shares. The mentioned changes placed institutional holdings at 946,256 shares, according to the latest SEC report filing. GOVX stock had 6 new institutional investments in for a total of 537,950 shares, while 5 institutional investors sold positions of 50,502 shares during the same period.